Zenotech [ZENOTECH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Zenotech Laboratories Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zenotech Laboratories Ltd. wins in 6 metrics, Sun Pharmaceutical Industries Ltd. wins in 12 metrics, with 1 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zenotech Laboratories Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 82.73 36.73 Sun Pharmaceutical Industries Ltd.
Price-to-Book Ratio 2.82 5.15 Zenotech Laboratories Ltd.
Debt-to-Equity Ratio 0.00 6.68 Tie
PEG Ratio 5.79 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 18.68 23.61 Zenotech Laboratories Ltd.
Profit Margin (TTM) 8.02% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 20.84% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 20.84% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 5.84% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 5.06% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $56.25M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -29.00% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 6.62 7.05 Zenotech Laboratories Ltd.
Enterprise Value $2.50B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 5.97 6.66 Zenotech Laboratories Ltd.
Gross Profit Margin (TTM) 100.00% 80.96% Zenotech Laboratories Ltd.
Revenue per Share (TTM) $7 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $0.55 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.09 0.11 Zenotech Laboratories Ltd.

Zenotech Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

ZENOTECH
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zenotech Laboratories Ltd.0.13%-1.28%1.39%-1.00%-8.38%-3.38%
Sun Pharmaceutical Industries Ltd.-0.08%-2.77%-1.84%2.13%-0.53%4.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zenotech Laboratories Ltd.-29.00%-15.94%2.47%2.12%-12.79%-25.87%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Zenotech Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricZENOTECHSUNPHARMA
Market Information
Market Cap i₹2.78B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i7,8813,903,142
90 Day Avg. Volume i17,7463,253,866
Last Close₹44.69₹1,788.50
52 Week Range₹33.55 - ₹67.00₹1,548.00 - ₹1,916.60
% from 52W High-33.30%-6.68%
All-Time High₹173.59 (Oct 01, 2007)₹1,960.35 (Sep 30, 2024)
% from All-Time High-74.26%-8.77%
Growth Metrics
Quarterly Revenue Growth0.16%0.14%
Quarterly Earnings Growth0.14%0.16%
Financial Health
Profit Margin (TTM) i0.08%0.19%
Operating Margin (TTM) i0.21%0.26%
Return on Equity (TTM) i0.06%0.15%
Debt to Equity (MRQ) i0.006.68
Cash & Liquidity
Book Value per Share (MRQ)₹16.11₹324.46
Cash per Share (MRQ)₹5.27₹115.87
Operating Cash Flow (TTM) i₹69.82M₹110.84B
Levered Free Cash Flow (TTM) i₹56.13M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Zenotech Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricZENOTECH (Apr 26, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i82.7336.73
Forward P/E iN/A29.48
PEG Ratio i5.793.59
Price to Sales (TTM) i6.627.05
Price to Book (MRQ) i2.825.15
Market Capitalization
Market Capitalization i₹2.78B₹3.88T
Enterprise Value i₹2.50B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i5.976.66
Enterprise to EBITDA i18.6823.61
Risk & Other Metrics
Beta i0.090.11
Book Value per Share (MRQ) i₹16.11₹324.46

Financial Statements Comparison: Zenotech Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZENOTECH (2025)SUNPHARMA (2025)
Revenue/Sales i389.76M520.41B
Cost of Goods Sold i52.64M121.98B
COGS % of Revenue i13.5%23.4%
Gross Profit i337.11M398.44B
Gross Margin i86.5%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i31.79M125.81B
Operating Margin i8.2%24.2%
EBITDA i157.24M167.25B
EBITDA Margin i40.3%32.1%
Pre-Tax Income i106.92M137.52B
Pre-Tax Income % of Revenue i27.4%26.4%
Income Tax i50.79M27.72B
Income Tax % of Revenue i13.0%5.3%
Net Income (Profit) i56.13M109.65B
Profit Margin i14.4%21.1%

Balance Sheet & Liquidity Metrics

MetricZENOTECH (2025)SUNPHARMA (2025)
Cash & Equivalents i265.75M102.69B
Total Current Assets i359.89M526.24B
Total Current Assets % of Revenue i92.3%101.1%
Total Current Liabilities i125.87M181.94B
Total Current Liabilities % of Revenue i32.3%35.0%
Long-Term Debt i03.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i961.31M724.86B
Retained Earnings i-1.74B578.62B
Retained Earnings % of Revenue i-447.6%111.2%
Property, Plant & Equipment i22.30M100.36B

Cash Flow Statement Comparison

MetricZENOTECH (2025)SUNPHARMA (2025)
Operating Cash Flow i69.82M110.84B
Operating Cash Flow % of Revenue i17.9%21.3%
Capital Expenditures i-38.63M-20.68B
Free Cash Flow i56.25M119.44B
FCF Margin i14.4%23.0%
Debt Repayment i0-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricZENOTECHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i61.03M2.40B
Float Shares i11.70M1.07B
% Held by Insiders i84.53%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i15.47%15.69%

Dividend Analysis & Yield Comparison: Zenotech Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricZENOTECHSUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026